These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 16715133

  • 1. Dual role of TMS1/ASC in death receptor signaling.
    Parsons MJ, Vertino PM.
    Oncogene; 2006 Nov 02; 25(52):6948-58. PubMed ID: 16715133
    [Abstract] [Full Text] [Related]

  • 2. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X, Kandasamy K, Srivastava RK.
    Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723
    [Abstract] [Full Text] [Related]

  • 3. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.
    Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST, Vertino PM.
    Cancer Res; 2000 Nov 15; 60(22):6236-42. PubMed ID: 11103776
    [Abstract] [Full Text] [Related]

  • 4. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H, Ooya K.
    J Oral Pathol Med; 2005 May 15; 34(5):287-94. PubMed ID: 15817072
    [Abstract] [Full Text] [Related]

  • 5. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M, Weller M.
    Cell Death Differ; 2003 Sep 15; 10(9):1078-89. PubMed ID: 12934082
    [Abstract] [Full Text] [Related]

  • 6. Mechanism and repertoire of ASC-mediated gene expression.
    Hasegawa M, Imamura R, Motani K, Nishiuchi T, Matsumoto N, Kinoshita T, Suda T.
    J Immunol; 2009 Jun 15; 182(12):7655-62. PubMed ID: 19494289
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy.
    Xu J, Zhou JY, Wu GS.
    Cancer Res; 2006 Oct 15; 66(20):10092-9. PubMed ID: 17047073
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways.
    Berg D, Stühmer T, Siegmund D, Müller N, Giner T, Dittrich-Breiholz O, Kracht M, Bargou R, Wajant H.
    FEBS J; 2009 Dec 15; 276(23):6912-27. PubMed ID: 19895579
    [Abstract] [Full Text] [Related]

  • 15. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
    Jiang CC, Chen LH, Gillespie S, Kiejda KA, Mhaidat N, Wang YF, Thorne R, Zhang XD, Hersey P.
    Cancer Res; 2007 Jun 15; 67(12):5880-8. PubMed ID: 17575157
    [Abstract] [Full Text] [Related]

  • 16. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V, Mitsiades CS, McMullan C, Fanourakis G, Negri J, Goudopoulou A, Halikias IX, Voutsinas G, Tseleni-Balafouta S, Miller JW, Mitsiades N.
    Invest Ophthalmol Vis Sci; 2005 Jan 15; 46(1):358-66. PubMed ID: 15623796
    [Abstract] [Full Text] [Related]

  • 17. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM, Ramachandran K, Vanwert J, Ferdinand L, Gopisetty G, Reis IM, Singal R.
    Mol Cancer; 2006 Jul 18; 5():28. PubMed ID: 16848908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.